All Stories

  1. Feasibility, safety and tolerability of intradialytic creatine supplementation in hemodialysis: A double-blind, randomized, placebo-controlled pilot study
  2. Interpretation of kidney outcomes during combined SGLT2 inhibitor and GLP-1 receptor agonist therapy
  3. Questioning the kidney-protective effects of tolvaptan: a testable hypothesis to revisit the current narrative
  4. Anthropometry-Adjusted TyG Indices Predict Diabetes, Graft Failure, and Mortality in Kidney Transplant Recipients
  5. Plasma Symmetric Dimethylarginine and Mortality in Kidney Transplant Recipients
  6. Deceased kidney donor cystatin C and subsequent recipient measured glomerular filtration rate at one year after transplantation
  7. SGLT2 Inhibitors, Muscle Loss, and Creatinine-Based Estimated GFR: An Integrative Conceptual Review of Renoprotection
  8. 305.7: Deceased kidney donor cystatin C and subsequent recipient kidney function one year after transplantation.
  9. Questioning the kidney-protective effect of tolvaptan: a biologically plausible hypothesis to revisit the current narrative
  10. Higher circulating FGF21, lower protein intake, and lower muscle mass: Associations with a higher risk of mortality
  11. Deterioration in Renal Function in Patients With a Fontan Circulation and Association With Mortality
  12. Sparsentan and kidney protection: improved medullary oxygenation?
  13. Adapting Clinical and Research Practice to Global Warming
  14. Comment on Zu et al. Association of Body Weight Time in Target Range With the Risk of Kidney Outcomes in Patients With Overweight/Obesity and Type 2 Diabetes Mellitus. Diabetes Care 2024;47:371–378
  15. [99mTc]Tc-hydroxydiphosphonate uptake in soft tissue is associated with amyloid load in subcutaneous abdominal fat tissue and mortality in wild-type transthyretin amyloidosis patients
  16. Iron deficiency, anemia, and patient-reported outcomes in kidney transplant recipients
  17. Creatinine, cystatin C, muscle mass, and mortality: Findings from a primary and replication population‐based cohort
  18. Creatine homeostasis and the kidney: comparison between kidney transplant recipients and healthy controls
  19. Potential Mediating Role of Iron Biomarkers in the Association of Sex With Glucose, Insulin, and Type 2 Diabetes
  20. Plasma symmetric dimethylarginine and kidney graft function in kidney transplant recipients
  21. Acoramidis in Transthyretin Amyloid Cardiomyopathy
  22. Evaluating the effect of bempedoic acid on kidney function: call for cautious implementation
  23. Sparsentan versus Irbesartan in Focal Segmental Glomerulosclerosis
  24. Development and External Validation of a Home-based Risk Prediction Model of Natural Onset of Menopause—Teuta
  25. Utility of iron biomarkers in differentiating menopausal status: Findings from CoLaus and PREVEND
  26. Integer Cystatin C Values: Impact on Discordance Group Assignment and Accuracy of GFR-Estimating Equations
  27. Rounding creatinine, cystatin C, or both: impact on discordance group assignment and GFR-estimating equation performance
  28. Tolvaptan, Kidney Function Decline, and Potential Confounding by Muscle Wasting
  29. Changes in Iron Status Biomarkers with Advancing Age According to Sex and Menopause: A Population-Based Study
  30. Comparison of anal function and quality of life after conformal sphincter preservation operation and intersphincteric resection of very low rectal cancer: a multicenter, retrospective, case–control analysis
  31. Transitions across Kidney Disease Stages and Association with New-onset Heart Failure: a Population-Based study of 8569 Individuals and 12.6 Years of Follow-up
  32. Dietary lithium intake, graft failure and mortality in kidney transplant recipients
  33. Circulating FGF21 Concentration, Fasting Plasma Glucose, and the Risk of Type 2 Diabetes: Results From the PREVEND Study
  34. Sex and N-terminal pro B-type natriuretic peptide: The potential mediating role of iron biomarkers
  35. Population-Based Limits of Urine Creatinine Excretion
  36. Letter by Groothof et al Regarding Article, “Efpeglenatide and Clinical Outcomes With and Without Concomitant Sodium-Glucose Cotransporter-2 Inhibition Use in Type 2 Diabetes: Exploratory Analysis of the AMPLITUDE-O Trial”
  37. Amino Acid Homeostasis and Fatigue in Chronic Hemodialysis Patients
  38. Reply to Janssen et al. Comment on “Kremer et al. Kidney Function-Dependence of Vitamin K-Status Parameters: Results from the TransplantLines Biobank and Cohort Studies. Nutrients 2021, 13, 3069”
  39. Muscle mass and estimates of renal function: a longitudinal cohort study
  40. Plasma Thallium Concentration, Kidney Function, Nephrotoxicity and Graft Failure in Kidney Transplant Recipients
  41. Effects of Magnesium Citrate, Magnesium Oxide, and Magnesium Sulfate Supplementation on Arterial Stiffness: A Randomized, Double‐Blind, Placebo‐Controlled Intervention Trial
  42. Response to Comment on Oosterwijk et al. High-Normal Protein Intake Is Not Associated With Faster Renal Function Deterioration in Patients With Type 2 Diabetes: A Prospective Analysis in the DIALECT Cohort. Diabetes Care 2022;45:35–41
  43. Gait speed reference values in community-dwelling older adults – Cross-sectional analysis from the Rotterdam Study
  44. Ertugliflozin, renoprotection and potential confounding by muscle wasting
  45. Plasma Lead Concentration and Risk of Late Kidney Allograft Failure: Findings From the TransplantLines Biobank and Cohort Studies
  46. Efpeglenatide and Heart and Kidney Outcomes in Type 2 Diabetes
  47. The simple observational critical care studies: estimations by students, nurses, and physicians of in-hospital and 6-month mortality
  48. Plasma neutrophil gelatinase-associated lipocalin and kidney graft outcome
  49. High-Normal Protein Intake Is Not Associated With Faster Renal Function Deterioration in Patients With Type 2 Diabetes: A Prospective Analysis in the DIALECT Cohort
  50. Boron Intake and decreased risk of mortality in kidney transplant recipients
  51. Low Circulating Concentrations of Very Long Chain Saturated Fatty Acids Are Associated with High Risk of Mortality in Kidney Transplant Recipients
  52. Kidney Function-Dependence of Vitamin K-Status Parameters: Results from the TransplantLines Biobank and Cohort Studies
  53. Plasma creatine concentration is associated with incident hypertension in a cohort enriched for the presence of high urinary albumin concentration: the Prevention of Renal and Vascular Endstage Disease study
  54. Nonalcoholic fatty liver disease, circulating ketone bodies and all‐cause mortality in a general population‐based cohort
  55. Fibroblast growth factor 21 and protein energy wasting in hemodialysis patients
  56. Urinary 3-hydroxyisovaleryl carnitine excretion, protein energy malnutrition and risk of all-cause mortality in kidney transplant recipients: Results from the TransplantLines cohort studies
  57. Creatine homeostasis and protein energy wasting in hemodialysis patients
  58. Reduced Vitamin K Status and Coronavirus Disease 2019: An Epiphenomenon of Impaired Kidney Function?
  59. Muscle mass versus body mass index as predictor of adverse outcome
  60. Relationship between body mass index, cardiovascular biomarkers and incident heart failure
  61. Plasma creatine and incident type 2 diabetes in a general population‐based cohort: The PREVEND study
  62. Association of beta‐hydroxybutyrate with development of heart failure: Sex differences in a Dutch population cohort
  63. Functional vitamin K status and risk of incident chronic kidney disease and microalbuminuria: a prospective general population-based cohort study
  64. Methylmalonic acid, vitamin B12, renal function, and risk of all-cause mortality in the general population: results from the prospective Lifelines-MINUTHE study
  65. Vibration threshold in non-diabetic subjects
  66. Plasma cadmium is associated with increased risk of long-term kidney graft failure
  67. Anemia and iron metabolism in COVID-19: a systematic review and meta-analysis
  68. Thyroid function and risk of all-cause and cardiovascular mortality: a prospective population-based cohort study
  69. Sodium–Glucose Cotransporter 2 Inhibitors and Kidney Outcomes: True Renoprotection, Loss of Muscle Mass or Both?
  70. Bone Mineral Density and Aortic Calcification: Evidence for a Bone-vascular Axis After Kidney Transplantation
  71. Circulating Arsenic is Associated with Long-Term Risk of Graft Failure in Kidney Transplant Recipients: A Prospective Cohort Study
  72. Regression of Bone-Tracer Uptake in Cardiac Transthyretin Amyloidosis
  73. Association of Plasma Concentration of Vitamin B12With All-Cause Mortality in the General Population in the Netherlands
  74. Concentration of Branched-Chain Amino Acids Is a Strong Risk Marker for Incident Hypertension
  75. Plasma Vitamin C and Cancer Mortality in Kidney Transplant Recipients